Scholars Central

Conference abstractPublished 20 Nov 2013

Yin and Yang of the Fas pathway in regulating self-tolerance

Authors: Abdel Rahim A. Hamad

Johns Hopkins University School of Medicine, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Type1 diabetes (T1D) results from autoimmune destruction of pancreatic insulin-producing Ã?Â?-cells. Autoreactive T cells are activated by islet autoantigens in pancreatic lymph nodes (PLN) from where they infiltrate pancreatic islets of Langerhans to cause insulitis and Ã?Â?-cell destruction. Although present within the normal repertoire of healthy individuals, autoreactive T cells are held in check by suppressive cytokines and specialized subsets of regulatory cells. In disease-susceptible individuals and the widely used âÂ?Â?non-obese diabetic (NOD) mouse model,âÂ? these immunoregulatory mechanisms fail, thereby permitting diabetogenic T cells to infiltrate islets, cause insulitis, and destroy Ã?Â?-cells. What causes these mechanisms to fail and how the failures can be avoided/rectified are current questions of paramount scientific and clinical significance. Our group is interested in understanding mechanisms that potently control Ã?Â?-cell-specific autoreactive T-cells when Fas ligand (FasL), an apoptosisinducing member of the tumor necrosis factor (TNF) family, is genetically or pharmacologically inactivated. Disruption of the Fas pathway causes massive T cell lymphoproliferation but instead of causing or aggravating organ specific autoimmunity, as is the case with CTLA-4 or Foxp3 deficiency, it restores organ-specific T cell tolerance in several autoimmune models. This paradox is best illustrated in NOD mice carrying homozygous gld or lpr mutations. Our mouse data support the hypothesis that defects in IL-10 utilization underlie autoimmune diabetes and that IL-10- producing B cells induced in pancreata by inactivating FasL are capable of controlling diabetogenic T cells. We will discuss the role of FasL in compromising and negating the role of IL-10 in antagonizing the diabetogenic process especially at the effector site, the pancreas.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Abdel Rahim A. Hamad”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels